Compugen (Israel) Today

CGEN Stock  ILA 910.00  1.40  0.15%   

Performance

7 of 100

 
Low
 
High
OK

Odds Of Distress

Less than 11

 
100  
 
Zero
Low
Compugen is trading at 910.00 as of the 28th of March 2024, a -0.15 percent decrease since the beginning of the trading day. The stock's open price was 911.4. Compugen has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but did not have a good performance during the last 90 trading days. Equity ratings for Compugen are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of February 2024 and ending today, the 28th of March 2024. Click here to learn more.
Compugen Ltd., a clinical-stage therapeutic discovery and development company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel, the United States, and Europe. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel. The company has 86.62 M outstanding shares. More on Compugen

Moving together with Compugen Stock

  0.8ENLV Enlivex TherapeuticsPairCorr

Moving against Compugen Stock

  0.8BLRX BioLine RXPairCorr
  0.76KTOV Purple BiotechPairCorr
  0.76PPBT Purple BiotechPairCorr
  0.63SKBN Shikun BinuiPairCorr
  0.42DLEKG Delek Group Earnings Call TodayPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Compugen Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Compugen's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Compugen or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOAnat CohenDayag
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
Compugen (CGEN) is traded on Tel Aviv Stock Exchange in Israel and employs 73 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 251.35 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Compugen's market, we take the total number of its shares issued and multiply it by Compugen's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Compugen operates under Healthcare sector and is part of Biotechnology industry. The entity has 86.62 M outstanding shares. Compugen has accumulated about 110.41 M in cash with (22.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.32.
Check Compugen Probability Of Bankruptcy
Ownership Allocation
Compugen holds a total of 86.62 Million outstanding shares. Compugen shows 5.5 percent of its outstanding shares held by insiders and 27.56 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Compugen Ownership Details

Compugen Stock Price Odds Analysis

What are Compugen's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Compugen jumping above the current price in 90 days from now is about 22.5%. The Compugen probability density function shows the probability of Compugen stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon the stock has a beta coefficient of 4.9688 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Compugen will likely underperform. In addition to that, compugen has an alpha of 2.4439, implying that it can generate a 2.44 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 910.0HorizonTargetOdds Above 910.0
77.44%90 days
 910.00 
22.50%
Based on a normal probability distribution, the odds of Compugen to move above the current price in 90 days from now is about 22.5 (This Compugen probability density function shows the probability of Compugen Stock to fall within a particular range of prices over 90 days) .

Compugen Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Compugen market risk premium is the additional return an investor will receive from holding Compugen long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Compugen. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Compugen's alpha and beta are two of the key measurements used to evaluate Compugen's performance over the market, the standard measures of volatility play an important role as well.

Compugen Stock Against Markets

Picking the right benchmark for Compugen stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Compugen stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Compugen is critical whether you are bullish or bearish towards Compugen at a given time. Please also check how Compugen's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Compugen without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Funds Screener Now

   

Funds Screener

Find actively-traded funds from around the world traded on over 30 global exchanges
All  Next Launch Module

Compugen Corporate Directors

Compugen corporate directors refer to members of a Compugen board of directors. The board of directors generally takes responsibility for the Compugen's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Compugen's board members must vote for the resolution. The Compugen board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Joshua ShemerIndependent External DirectorProfile
Ruth ArnonIndependent DirectorProfile
Yair AharonowitzIndependent External DirectorProfile
Michal PremingerDirectorProfile

How to buy Compugen Stock?

Before investing in Compugen, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Compugen. To buy Compugen stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Compugen. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Compugen stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Compugen stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Compugen stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Compugen, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Compugen Stock please use our How to Invest in Compugen guide.

Already Invested in Compugen?

The danger of trading Compugen is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Compugen is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Compugen. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Compugen is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Compugen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Compugen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Compugen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Compugen Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Compugen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Compugen Stock refer to our How to Trade Compugen Stock guide.
You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Compugen Stock analysis

When running Compugen's price analysis, check to measure Compugen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compugen is operating at the current time. Most of Compugen's value examination focuses on studying past and present price action to predict the probability of Compugen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compugen's price. Additionally, you may evaluate how the addition of Compugen to your portfolios can decrease your overall portfolio volatility.
Commodity Directory
Find actively traded commodities issued by global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Please note, there is a significant difference between Compugen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Compugen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Compugen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.